[A2k] Infojustice Roundup - August 6, 2012

Michael Palmedo mpalmedo at wcl.american.edu
Mon Aug 6 13:36:32 PDT 2012

Infojustice Roundup  


U.S. Proposal for Limitations and Exceptions to Copyright in the TPP


Over the weekend, the U.S. proposal for limitations and exceptions to
copyright in the Trans Pacific Partnership was leaked by KEI, and is
available along with a statement here <http://keionline.org/node/1516> .
Earlier this week, PIJIP Professors Peter Jaszi, Michael Carroll and
Sean Flynn released a statement on the U.S. proposal, calling it "a
first response by the U.S. to the growing chorus of calls for increased
attention to the need for international harmonization of mandatory
minimum limitations and exceptions to intellectual property rights" but
warning that "the inclusion of a U.S.-version of a three-step test in
the TPP would cause numerous potential problems for the kind of balance
in copyright systems that the new USTR proposal claims to advance." The
full statement is available here <http://infojustice.org/archives/26799>
.  See also the EFF statement, available here
> .


La Quadrature du Net: Proposals for the Reform of Copyright and Related
Culture and Media Policy


[repost from La Quadrature du Net] Now that the ACTA treaty has been
rejected by the European Parliament, a period opens during which it will
be possible to push for a new regulatory and policy framework adapted to
the digital era. Many citizens and MEPs support the idea of reforming
copyright in order to make possible for all to draw the benefits of the
digital environment, engage into creative and expressive activities and
share in their results. In the coming months and years, the key
questions will be: What are the real challenges that this reform should
address? How can we address them? Click here for more.


Hetero Joins Patent Pool; Signing License to Produce Low-Cost HIV


Hyderabad-based Hetero Labs has signed a license agreement with the
Medicines Patent Pool that will allow it to produce key HIV medicines
for a number of developing countries. The agreement will allow Hetero to
produce four key medicines originally developed by Gilead Sciences -
emtricitabine, cobicistat, and elvitegravir, and a combination of these
medicines plus a fourth drug, tenofovir, in a single pill known as the
"Quad" - in 100 to 112 countries. These medicines were licensed to the
Pool by Gilead Sciences in July 2011. Click here for the full press
release on the MPP website.


Draft 2 of Creative Commons Licenses 4.0 Ready for Public Comment


[blog by Diane Peter on creativecommons.org] We are pleased to post
draft 2 of 4.0 for public discussion. This comes after several months of
substantive conversations on a number of policy issues, with input
solicited from our global community on the CC license-development list
(archive), through affiliate consultations, via comments posted directly
on our 4.0 wiki, and submissions to staff. Click here for more. Click
here for more. <http://infojustice.org/archives/26859> 



More information about the A2k mailing list